HTG Molecular Diagnostics Inc (HTGM)
HTG Molecular Diagnostics is a commercial stage RNA platform-based life sciences company focused on developing medicine. Co.'s product and service solutions are based on its digital HTG EdgeSeq technology that enables RNA profiling using a small amount of biological sample, in liquid or solid forms. Co. markets proprietary molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. Co.'s marketed panels include: HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq Precision Immuno-Oncology Panel; HTG Lung Fusions Assay;HTG Autoimmune Panel; HTG EdgeSeq Immuno-Oncology Assay; and HTG Mouse mRNA Tumor Response Panel.
|
April 18, 2024 9:32 AM Eastern
Strong Buy (4.00 out of 4)
100th percentile
|
|